Social Anxiety Disorder Treatment Study
The purpose of this study is to find out if d-cycloserine (DCS) improves the effectiveness of cognitive behavioral therapy (CBT) in reducing symptoms associated with social anxiety disorder. During this 6-week study, participants will receive five sessions of cognitive behavioral therapy; and at four of these sessions, participants will take either DCS or a placebo (an inactive pill). Throughout the study, participants’ symptoms will be assessed using questionnaires, interviews, and lab tests. Participants will also be asked to attend a one month and a three month follow-up visit. All study-related procedures, psychiatric evaluation, medication, therapy, and transportation are free.
In order to participate you must meet the following criteria:
- Be male or female outpatients, > 18 years of age.
- Have a primary psychiatric diagnosis (designated by the patient as the most important source of current distress) of social anxiety disorder as defined by DSM-5 criteria.
This is a partial list of inclusion criteria.